Suppr超能文献

评估 SARS CoV-2 在工作场所中的感染情况,以支持运营的连续性。

Benchmarking SARS CoV-2 Infection in the Workplace to Support Continuity of Operations.

机构信息

Health Services Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee (Dr Iddins, Dr Waugh, Mr Buck, Ms Cato, Mr Attia, Mr Jones, Mr Partin, Ms Shourbaji, and Mr Wesh); University of Tennessee, Knoxville, Tennessee (Dr Waugh); Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee (Dr Graham).

出版信息

J Occup Environ Med. 2021 Jul 1;63(7):548-556. doi: 10.1097/JOM.0000000000002188.

Abstract

OBJECTIVE

The COVID-19 pandemic jeopardizes continuity of operations of workplaces and the health and safety of workers. Exemplar workplace-related SARS-CoV-2 benchmarks are described and illustrated with empirical data.

METHODS

Benchmarks were collected over a 9-month period on a large workplace (N = 5500+). These ranged from quantitative indices associated with RT-qPCR targeted testing and random surveillance screening, surveillance for new variants of SARS-CoV-2, intensive contact tracing, case management, return to work procedures, to monitoring of antibody seropositive status.

RESULTS

Data and analyses substantiated effectiveness of interventions. This was evidenced in suppressed infection rates, rapid case identification and isolation, acceptance of the program by employees, documentation of presumptive immunity, and working relationships with senior management.

CONCLUSIONS

These SARS-CoV-2 exemplar benchmarks provided an evidence-base for practice and contributed strategically to organizational decisions.

摘要

目的

COVID-19 大流行危及工作场所的运营连续性和工人的健康与安全。本文描述了与工作场所相关的 SARS-CoV-2 基准,并结合实证数据进行了说明。

方法

在为期 9 个月的时间里,对一个大型工作场所(N=5500+)进行了基准收集。这些基准包括与 RT-qPCR 靶向检测和随机监测筛查、SARS-CoV-2 新变体监测、强化接触者追踪、病例管理、返工程序以及抗体血清阳性状态监测相关的定量指标。

结果

数据和分析证实了干预措施的有效性。这表现在感染率的降低、病例的快速识别和隔离、员工对该计划的接受程度、假定免疫力的记录以及与高级管理层的工作关系。

结论

这些 SARS-CoV-2 基准为实践提供了证据基础,并为组织决策提供了战略性贡献。

相似文献

1
Benchmarking SARS CoV-2 Infection in the Workplace to Support Continuity of Operations.
J Occup Environ Med. 2021 Jul 1;63(7):548-556. doi: 10.1097/JOM.0000000000002188.
2
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD015112. doi: 10.1002/14651858.CD015112.pub3.
3
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
Cochrane Database Syst Rev. 2022 May 6;5(5):CD015112. doi: 10.1002/14651858.CD015112.pub2.
4
Model for Mitigation of Workplace Transmission of COVID-19 Through Population-Based Testing and Surveillance.
Popul Health Manag. 2021 Feb;24(S1):S16-S25. doi: 10.1089/pop.2020.0322. Epub 2021 Jan 25.
5
A network modelling approach to assess non-pharmaceutical disease controls in a worker population: An application to SARS-CoV-2.
PLoS Comput Biol. 2021 Jun 16;17(6):e1009058. doi: 10.1371/journal.pcbi.1009058. eCollection 2021 Jun.
7
Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.
mSphere. 2021 Aug 25;6(4):e0054221. doi: 10.1128/mSphere.00542-21. Epub 2021 Jul 7.
9
Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
J Med Internet Res. 2021 Feb 3;23(2):e25799. doi: 10.2196/25799.
10
COVID-19 Prevention and Control Measures in Workplace Settings: A Rapid Review and Meta-Analysis.
Int J Environ Res Public Health. 2021 Jul 24;18(15):7847. doi: 10.3390/ijerph18157847.

引用本文的文献

1
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD015112. doi: 10.1002/14651858.CD015112.pub3.
2
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
Cochrane Database Syst Rev. 2022 May 6;5(5):CD015112. doi: 10.1002/14651858.CD015112.pub2.
3
Returning to Work after the COVID-19 Pandemic Earthquake: A Systematic Review.
Int J Environ Res Public Health. 2022 Apr 9;19(8):4538. doi: 10.3390/ijerph19084538.

本文引用的文献

3
Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):95-99. doi: 10.15585/mmwr.mm7003e2.
6
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
N Engl J Med. 2021 Feb 11;384(6):533-540. doi: 10.1056/NEJMoa2034545. Epub 2020 Dec 23.
7
COVID-19 as the Leading Cause of Death in the United States.
JAMA. 2021 Jan 12;325(2):123-124. doi: 10.1001/jama.2020.24865.
8
COVID-19: Pandemic of Cognitive Biases Impacting Human Behaviors and Decision-Making of Public Health Policies.
Front Public Health. 2020 Nov 24;8:613290. doi: 10.3389/fpubh.2020.613290. eCollection 2020.
9
10
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
Cell. 2021 Jan 7;184(1):169-183.e17. doi: 10.1016/j.cell.2020.11.029. Epub 2020 Nov 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验